Macrogenics reported $-63725000 in EBITDA for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Abbvie ABBV:US $ 7127M 482M
Amgen AMGN:US $ 3341M 185M
AstraZeneca AZN:LN 4187M 687M
Biogen BIIB:US $ 674.7M 20.2M
Bristol Myers Squibb BMY:US $ 5772M 404M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Daiichi Sankyo 4568:JP Y -35701M 88958M
Eli Lilly And LLY:US $ 3005.6M 161.6M
Epizyme EPZM:US $ -49.63M 0.33M
Geron GERN:US $ -28.62M 2.3M
Gilead Sciences GILD:US $ 3422M 1947M
Immunogen IMGN:US $ -22.38M 11.71M
Johnson & Johnson JNJ:US $ 9309M 1549M
Karyopharm Therapeutics KPTI:US $ -34409000 81.51M
Macrogenics MGNX:US $ -63725000 8.44M
Merk MRK:US $ 6179M 492M
Mirati Therapeutics MRTX:US $ -183.59M 12.92M
Pfizer PFE:US $ 11182M 4046M
Puma Biotechnology PBYI:US $ 1.52M 7.59M
Regeneron Pharmaceuticals REGN:US $ 1360.9M 1353.3M
Seattle Genetics SGEN:US $ -115.96M 37.85M
Xencor XNCR:US $ 28.64M 65.11M